He, Weilei
Xu, Mengmeng
Lin, Ru
Wang, Shu
Huang, Wenjie
Chen, Haisong
Yang, Yunjun
Funding for this research was provided by:
the Wenzhou Major Program of Science and Technology Innovation (ZY2020012)
Key Laboratory of Novel Nuclide Technologies on Precision Diagnosis and Treatment & clinical Transformation of Wenzhou City (2023HZSY0012)
Article History
Received: 3 June 2025
Accepted: 25 November 2025
First Online: 4 December 2025
Declarations
:
: This study was approved by the Clinical Application Management Committee for Medical Technologies at the First Affiliated Hospital of Wenzhou Medical University (Approval No. YLJS-2018-005), which serves as the institutional review board (IRB) for this study. Due to the anonymity and retrospective nature of the data, the need for written informed consent was waived by the same committee. All study procedures and protocols complied with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.